Description

LINEVESTA Tablets contain Linezolid, an advanced antibiotic designed for effective management of resistant Gram-positive infections, including MRSA.

⚡ Outstanding Gram-Positive Coverage

• Highly active against:
  • MRSA (Methicillin-resistant Staphylococcus aureus)
  • Streptococci
  • Enterococci (including resistant strains)
• Ideal for multi-drug-resistant infections

🔬 Proven Clinical Efficacy

• 89% clinical success in skin & soft tissue infections
• 98% cure rate in community-acquired pneumonia
• Effective for both complicated & uncomplicated infections

🏥 Clinical Advantages

• Suitable for long-term outpatient therapy
• Excellent oral bioavailability
• Strong tissue penetration, including lungs and skin

🏥 Indications

• Nosocomial Pneumonia
• Community-Acquired Pneumonia (CAP)
• Complicated & Uncomplicated Skin & Soft Tissue Infections
• CNS Infections
• Urinary Tract Infections

💡 Why Choose LINEVESTA?

• Advanced solution for resistant Gram-positive infections
• Reliable in hospital and outpatient settings
• Helps improve clinical outcomes in difficult cases

👉 LINEVESTA – Precision Therapy Against Resistant Gram-Positive Infections.